|
Market Closed -
Other stock markets
|
After hours 08:00:00 | |||
| 297.69 USD | +1.89% |
|
298.38 | +0.23% |
| Market Cap | 39.75B 34.38B 31.68B 29.69B 55.46B 3,790B 56.47B 376B 146B 1,833B 149B 146B 6,370B | P/E ratio 2026 * |
38.9x | P/E ratio 2027 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise value | 36.81B 31.84B 29.34B 27.5B 51.36B 3,510B 52.3B 348B 135B 1,698B 138B 135B 5,899B | EV / Sales 2026 * |
6.56x | EV / Sales 2027 * | 4.77x |
| Free-Float |
99.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alnylam Pharmaceuticals, Inc.
| 1 day | +1.89% | ||
| 1 week | +4.04% | ||
| Current month | -1.42% | ||
| 1 month | +0.89% | ||
| 3 months | -8.00% | ||
| 6 months | -28.30% | ||
| Current year | -25.14% |
| 1 week | 285.54 |  | 310.53 |
| 1 month | 283.1 | | 310.53 |
| Current year | 283.1 | | 427.05 |
| 1 year | 283.1 | | 495.55 |
| 3 years | 141.98 | | 495.55 |
| 5 years | 117.58 | | 495.55 |
| 10 years | 31.38 | | 495.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/01/2022 | |
Jeffrey Poulton
DFI | Director of Finance/CFO | 58 | 13/08/2019 |
| Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 80 | 23/04/2012 |
Amy Schulman
CHM | Chairman | 65 | 05/01/2023 |
David Pyott
BRD | Director/Board Member | 72 | 18/12/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-01 | Free | Director | 4,393 | 0.0033% | ||
| 06-01 | Fiscal year | Director | 11,490 | 0.0086% | ||
| 05-20 | Free | Director | 2,112 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.89% | +4.04% | -2.08% | +56.00% | 39.01B | |
| -0.39% | +7.57% | +47.95% | +156.63% | 1,025B | |
| +2.08% | +6.33% | +52.68% | +48.12% | 559B | |
| +1.05% | +4.65% | +19.17% | +63.14% | 394B | |
| +0.77% | +5.62% | +21.96% | +15.95% | 324B | |
| -1.19% | +3.16% | +26.55% | +16.39% | 286B | |
| +0.89% | +4.76% | +21.94% | +31.29% | 270B | |
| -0.34% | +4.97% | +18.82% | +57.51% | 187B | |
| -0.92% | -2.94% | -45.04% | -50.62% | 186B | |
| -2.03% | -1.62% | +11.06% | +60.65% | 159B | |
| Average | +0.18% | +2.54% | +17.30% | +45.50% | 342.91B | |
| Weighted average by Cap. | +0.25% | +4.56% | +30.20% | +71.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.61B 4.85B 4.47B 4.19B 7.83B 535B 7.97B 53.05B 20.59B 259B 21.07B 20.61B 899B | 7.3B 6.31B 5.82B 5.45B 10.19B 696B 10.37B 69.02B 26.78B 337B 27.41B 26.82B 1,170B |
| Net income | 1.03B 887M 818M 766M 1.43B 97.8B 1.46B 9.7B 3.76B 47.3B 3.85B 3.77B 164B | 1.52B 1.31B 1.21B 1.14B 2.12B 145B 2.16B 14.37B 5.58B 70.08B 5.71B 5.58B 244B |
| Net Debt | -2.94B -2.54B -2.34B -2.19B -4.1B -280B -4.17B -27.77B -10.78B -135B -11.03B -10.79B -471B | -4.9B -4.24B -3.91B -3.66B -6.84B -467B -6.97B -46.35B -17.99B -226B -18.41B -18.01B -786B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/06/26 | 297.69 $ | +1.89% | 1,259,943 |
| 08/06/26 | 292.16 $ | -3.59% | 1,651,435 |
| 05/06/26 | 303.05 $ | -0.19% | 1,004,445 |
| 04/06/26 | 303.64 $ | +3.78% | 1,081,496 |
| 03/06/26 | 292.58 $ | +2.26% | 988,833 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALNY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition